Gujarat Inject (Kerala) Ltd.

10.15 -0.05 ▼-0.5%

04 October 2023, 04:01:00 PM
Volume: 2,645

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.gujaratinject.com
Market Cap 4.97 Cr.
Enterprise Value(EV) 5.58 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 0.12 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 81.52 Trailing Twelve Months Ending 2023-06
Industry PE 37.76 Trailing Twelve Months Ending 2023-06
Book Value / Share -1.63 Trailing Twelve Months Ending 2023-06
Price to Book Value -6.22 Calculated using Price: 10.15
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.49 Cr. 4,899,000 Shares
FaceValue 10
About Gujarat Inject (Kerala) Ltd.
Gujarat Inject (Kerala) (GKIL) was incorporated on January 7, 1991 and obtained certificate for commencement of business on February 14, 1991. The company has been jointly promoted by the Kerala State Industrial Development Corporation (KSIDC), a wholly owned subsidiary of Government of Kerala undertaking and Gujarat Inject (GIL) and its associates. The company has received SIA registration to manufacture intravenous solutions at puddussey east, kanjikode, in palghat district in Kerala.

Gujarat Inject (Kerala) Ltd. Delivery

Delivered Qty
Traded Qty

Gujarat Inject (Kerala) Ltd. Performance

1 Day
-0.49%
1 Week
+12.90%
1 Month
+12.78%
3 Month
+11.29%
6 Month
+26.88%
1 Year
+54.02%
2 Year
5 Year
10 Year

Gujarat Inject (Kerala) Ltd. Fundamental Ratios

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%)
Return on Capital Employed (%)
Return on Assets (%) -1.68 -1.84 1,373.74 6.93 -102.49 -30.20 1.57 -664.44 5.37

Gujarat Inject (Kerala) Ltd. Balance Sheet

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds -3 -3 -1 -1 -1 -1 -1 -1 -1 -1
Non Curr. Liab. 0 0 0 0 0 0 0 0 0
Curr. Liab. 3 3 1 0 0 0 0 0 1 1
Minority Int.
Equity & Liab. 0 0 0 0 0 0 0 0 0 0
Non Curr. Assets 0 0
Curr. Assets 0 0 0 0 0 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 0 0 0 0 0 0 0 0 0 0

Gujarat Inject (Kerala) Ltd. Profit and Loss

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 0 2 0 0 0
Other Income 0 0 0 0 0 0
Total Income 0 2 0 0 0 0 0 1
Total Expenditure 0 -2 0 0 0 0 0 -1
PBIDT 0 0 0 0 0
Interest
Depreciation
Taxation 0
Exceptional Items 2
PAT 2 0 0 0 0 0
Adjusted EPS 0 0 5 0 0 0 0 0

Gujarat Inject (Kerala) Ltd. Cash Flow

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0
Cash Fr. Inv.
Cash Fr. Finan. 0
Net Change 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0

Gujarat Inject (Kerala) Ltd. Shareholding Pattern

9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Public 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Gujarat Inject (Kerala) Ltd. Announcements

Sat, 30 Sep 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceeding of 32nd Annual General Meeting of Gujarat Inject (Kerala) Limited.
Sat, 30 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results of the 32nd Annual Genreal Meeting of the company held on Saturday September 30 2023.
Thu, 28 Sep 2023
Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and Companys Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities this is to inform that the trading window for dealing in Equity shares of the Company by the Insiders Covered under Companys Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities will be closed from Sunday October 1 2023 till 48 hours after the declaration and publication of Unaudited Financial results for the Quarter Ended September 30 2023.

Gujarat Inject (Kerala) Ltd. Technical Scans

Wed, 04 Oct 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Opening at High Opening at High
Opening at Low Opening at Low

Gujarat Inject (Kerala) Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 269,145.40 1,121.75 -1.8%
Divi's Laboratories Ltd. 98,393.27 3,702.05 -0.5%
Cipla Ltd. 94,222.95 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. 90,284.76 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. 72,588.97 5,048.70 -1.4%
Mankind Pharma Ltd. 72,396.35 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. 63,113.31 1,865.70 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 31.91 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 66.52 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 30.29 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.12 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.58 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 56.53 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.11 1,865.70 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.64 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 7.49 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 3.87 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.68 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.57 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 5.92 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.60 1,865.70 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,865.70 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,865.70 -0.8%

Gujarat Inject (Kerala) Ltd. FAQ's

What is Guj. Inject (Kerala) share price?

Can I buy Guj. Inject (Kerala) shares now?

What is the Market Cap of Guj. Inject (Kerala)?

What are the key metrics to analyse Guj. Inject (Kerala)?

What is the 52 Week High and Low of Guj. Inject (Kerala)?

What is the trend of Guj. Inject (Kerala) share price?